A novel ATP analog featuring a polyamine linker enables efficient kinase-catalyzed biotinylation within live cells by enhancing cell permeability.
Technology Summary
ATP (adenosine 5’-triphosphate) analogs such as ATP-biotin are widely used to monitor biochemical events in vitro. WSU researchers developed a specially designed ATP analog that replaces the conventional PEG linker with a positively charged polyamine linker, significantly improving cell permeability. This advancement allows the ATP analog to enter live cells and participate in kinase-catalyzed biotinylation, enabling detailed study of protein kinases and their substrates in physiologically relevant conditions. Experimental validation demonstrates successful intracellular protein labeling, overcoming the limitations of traditional ATP-biotin which is restricted to in vitro use. The invention supports enhanced research into cell signaling pathways critical to diseases such as cancer and diabetes.
Key Advantages
Market Opportunities
Stage of Development
Pre-Clinical.
Patent Status
Issued US patent 10,429,397
References & Publications
Fouda 2015, Angew Chem Int Ed. 54(33), 9618-21
https://doi.org/10.1002/anie.201503041